Journal of Audiology & Otology

The Korean Audiology Society (대한청각학회)
권호 표지
DOI QR코드

DOI QR Code

Comparison of the Effects of Intratympanic Steroid Injection at Different Intervals in Sudden Sensorineural Hearing Loss

  • Sung, Han Kyung (Department of Otorhinolaryngology-Head and Neck Surgery, Bundang Jesaeng Hospital, Daejin Medical Center) ;
  • Kang, Ju Chang (Department of Otorhinolaryngology-Head and Neck Surgery, Bundang Jesaeng Hospital, Daejin Medical Center) ;
  • Shin, Kyu Ha (Department of Otorhinolaryngology-Head and Neck Surgery, Bundang Jesaeng Hospital, Daejin Medical Center) ;
  • An, Yun Suk (Department of Otorhinolaryngology-Head and Neck Surgery, Bundang Jesaeng Hospital, Daejin Medical Center)
  • Received : 2019.07.31
  • Accepted : 2019.10.04
  • Published : 2020.01.20
⟨ Previous Next ⟩

Abstract

Background and Objectives: Systemic steroid therapy (SST) and intratympanic steroid injection (ISI) have been the treatment of choice for sudden sensorineural hearing loss (SSNHL). We studied the effect of ISI administered at different intervals on hearing outcomes in patients with SSNHL. Subjects and Methods: We performed a retrospective study of 427 patients diagnosed with SSNHL at Bundang Jesaeng Hospital, of whom 51 patients with SSNHL who received SST and four ISIs were included in this study. Patients were treated with four ISIs either every day for 4 days (group 1) or at intervals (mean duration of interval: 2.21 days) (group 2). Hearing outcomes were evaluated using the pure-tone test before the injection and 14 days, 1 month, and 3 months after the final injection. Recovery rates were classified based on Siegel's criteria. Results: The amount of improvement was 27.67 dB (±20.45) in group 1 and 32.79 dB (±21.42) in group 2. However, there were no significant differences between the two groups (p= 0.714). The recovery rates based on Siegel's criteria were 18/27 (66.7%) and 16/24 (66.7%) in groups 1 and 2, respectively, with no significant difference (p=1.000). Considering only complete recoveries in hearing recovery, the recovery rates were 15/27 (55.6%) and 14/24 (58.3%) in groups 1 and 2, respectively, with no significant difference (p=0.842). Conclusions: There were no significant differences in hearing outcomes or recovery rates after ISI administration every day or at intervals of 2-3 days.

Keywords

References

  1. Chau JK, Lin JR, Atashband S, Irvine RA, Westerberg BD. Systematic review of the evidence for the etiology of adult sudden sensorineural hearing loss. Laryngoscope 2010;120:1011-21. https://doi.org/10.1002/lary.20873
  2. Vijayendra H, Buggaveeti G, Parikh B, Sangitha R. Sudden sensorineural hearing loss: an otologic emergency. Indian J Otolaryngol Head Neck Surg 2012;64:1-4. https://doi.org/10.1007/s12070-010-0049-x
  3. Moskowitz D, Lee KJ, Smith HW. Steroid use in idiopathic sudden sensorineural hearing loss. The Laryngoscope 1984;94:664-6.
  4. Conlin AE, Parnes LS. Treatment of sudden sensorineural hearing loss: II. A Meta-analysis. Arch Otolaryngol Head Neck Surg 2007;133:582-6. https://doi.org/10.1001/archotol.133.6.582
  5. Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999;109(7 Pt 2):1-17. https://doi.org/10.1097/00005537-199907001-00001
  6. Chou YF, Chen PR, Kuo IJ, Yu SH, Wen YH, Wu HP. Comparison of intermittent intratympanic steroid injection and near-continual transtympanic steroid perfusion as salvage treatments for sudden sensorineural hearing loss. Laryngoscope 2013;123:2264-9. https://doi.org/10.1002/lary.23909
  7. Siegel LG. The treatment of idiopathic sudden sensorineural hearing loss. Otolaryngol Clin North Am 1975;8:467-73. https://doi.org/10.1016/s0030-6665(20)32783-3
  8. Hobson CE, Alexander TH, Harris JP. Primary treatment of idiopathic sudden sensorineural hearing loss with intratympanic dexamethasone. Curr Opin Otolaryngol Head Neck Surg 2016;24:407-12. https://doi.org/10.1097/MOO.0000000000000288
  9. Shirwany NA, Seidman MD, Tang W. Effect of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig. Am J Otol 1998;19:230-5.
  10. Lee JJ, Jang JH, Choo OS, Lim HJ, Choung YH. Steroid intracochlear distribution differs by administration method: systemic versus intratympanic injection. Laryngoscope 2018;128:189-94. https://doi.org/10.1002/lary.26562
  11. Hargunani CA, Kempton JB, DeGagne JM, Trune DR. Intratympanic injection of dexamethasone: time course of inner ear distribution and conversion to its active form. Otol Neurotol 2006;27:564-9. https://doi.org/10.1097/00129492-200606000-00021
  12. Kim YJ, Jang SU, Lee HH, Kwon JH. Comparison of the effect of intratympanic steroid injection medications in patients with idiopathic sudden sensorineural hearing loss. Korean J Otorhinolaryngol-Head Neck Surg 2017;60:441-8. https://doi.org/10.3342/kjorl-hns.2017.00311
  13. Sugihara EM, Evans MA, Neumann M, Babu SC. The effect of intratympanic steroid injection frequency in idiopathic sudden sensorineural hearing loss. Am J Otolaryngol 2018;39:688-92. https://doi.org/10.1016/j.amjoto.2018.07.013
  14. Suzuki H, Koizumi H, Ohkubo J, Hohchi N, Ikezaki S, Kitamura T. Hearing outcome does not depend on the interval of intratympanic steroid administration in idiopathic sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2016;273:3101-7. https://doi.org/10.1007/s00405-016-3930-8